Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 19.59
+0.02 (0.10%)
May 13, 2025, 3:04 PM CST
SHE:300122 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 16,825 | 25,846 | 52,914 | 38,260 | 30,629 | 15,156 | Upgrade
|
| Other Revenue | 223.28 | 223.28 | 4.08 | 3.85 | 23.46 | 34.23 | Upgrade
|
| Revenue | 17,049 | 26,070 | 52,918 | 38,264 | 30,652 | 15,190 | Upgrade
|
| Revenue Growth (YoY) | -67.92% | -50.73% | 38.30% | 24.83% | 101.79% | 43.48% | Upgrade
|
| Cost of Revenue | 12,154 | 18,971 | 38,986 | 25,518 | 15,728 | 9,316 | Upgrade
|
| Gross Profit | 4,895 | 7,099 | 13,932 | 12,746 | 14,925 | 5,875 | Upgrade
|
| Selling, General & Admin | 2,957 | 3,045 | 3,166 | 2,595 | 2,121 | 1,410 | Upgrade
|
| Research & Development | 964.64 | 971.37 | 968.47 | 854.16 | 552.63 | 299.65 | Upgrade
|
| Other Operating Expenses | 103.71 | 135.45 | 238.75 | 177.02 | 135.23 | 70.99 | Upgrade
|
| Operating Expenses | 4,546 | 4,761 | 4,725 | 4,047 | 3,000 | 1,863 | Upgrade
|
| Operating Income | 348.61 | 2,338 | 9,206 | 8,698 | 11,924 | 4,011 | Upgrade
|
| Interest Expense | -192.42 | -146.85 | -81 | -53.3 | -56.14 | -127.14 | Upgrade
|
| Interest & Investment Income | 43.96 | 66.63 | 67.94 | 46.09 | 61.47 | 11.98 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.67 | 1.67 | 2.28 | 15.4 | -10.1 | 3.84 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.5 | -37.32 | -36.56 | -22.64 | -17.23 | -19.61 | Upgrade
|
| EBT Excluding Unusual Items | 175.33 | 2,222 | 9,159 | 8,684 | 11,902 | 3,880 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.93 | - | - | - | -5.63 | -13.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.34 | 0.05 | 41.37 | 0.01 | 0.04 | -0 | Upgrade
|
| Asset Writedown | -37.67 | -0.36 | -0.13 | -0.09 | -1.68 | -0.55 | Upgrade
|
| Other Unusual Items | 44.74 | 32.05 | 142.34 | 34.31 | 35.83 | -12.34 | Upgrade
|
| Pretax Income | 186.81 | 2,254 | 9,342 | 8,718 | 11,931 | 3,854 | Upgrade
|
| Income Tax Expense | -68.78 | 235.21 | 1,272 | 1,179 | 1,723 | 552.75 | Upgrade
|
| Net Income | 255.59 | 2,018 | 8,070 | 7,539 | 10,209 | 3,301 | Upgrade
|
| Net Income to Common | 255.59 | 2,018 | 8,070 | 7,539 | 10,209 | 3,301 | Upgrade
|
| Net Income Growth | -96.59% | -74.99% | 7.04% | -26.15% | 209.23% | 39.51% | Upgrade
|
| Shares Outstanding (Basic) | 2,395 | 2,395 | 2,400 | 2,400 | 2,400 | 2,400 | Upgrade
|
| Shares Outstanding (Diluted) | 2,395 | 2,395 | 2,400 | 2,400 | 2,400 | 2,400 | Upgrade
|
| Shares Change (YoY) | -0.14% | -0.20% | - | - | -0.00% | 0.00% | Upgrade
|
| EPS (Basic) | 0.11 | 0.84 | 3.36 | 3.14 | 4.25 | 1.38 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.84 | 3.36 | 3.14 | 4.25 | 1.38 | Upgrade
|
| EPS Growth | -96.58% | -74.94% | 7.04% | -26.15% | 209.23% | 39.50% | Upgrade
|
| Free Cash Flow | -680.87 | -5,344 | 7,862 | 535.93 | 6,575 | 2,670 | Upgrade
|
| Free Cash Flow Per Share | -0.28 | -2.23 | 3.28 | 0.22 | 2.74 | 1.11 | Upgrade
|
| Dividend Per Share | 0.200 | 0.200 | 0.800 | 0.333 | 0.400 | 0.333 | Upgrade
|
| Dividend Growth | -75.00% | -75.00% | 140.02% | -16.68% | 20.01% | - | Upgrade
|
| Gross Margin | 28.71% | 27.23% | 26.33% | 33.31% | 48.69% | 38.67% | Upgrade
|
| Operating Margin | 2.04% | 8.97% | 17.40% | 22.73% | 38.90% | 26.41% | Upgrade
|
| Profit Margin | 1.50% | 7.74% | 15.25% | 19.70% | 33.30% | 21.73% | Upgrade
|
| Free Cash Flow Margin | -3.99% | -20.50% | 14.86% | 1.40% | 21.45% | 17.57% | Upgrade
|
| EBITDA | 735.99 | 2,710 | 9,518 | 9,003 | 12,297 | 4,132 | Upgrade
|
| EBITDA Margin | 4.32% | 10.40% | 17.99% | 23.53% | 40.12% | 27.20% | Upgrade
|
| D&A For EBITDA | 387.39 | 372.28 | 311.85 | 304.88 | 372.24 | 120.93 | Upgrade
|
| EBIT | 348.61 | 2,338 | 9,206 | 8,698 | 11,924 | 4,011 | Upgrade
|
| EBIT Margin | 2.04% | 8.97% | 17.40% | 22.73% | 38.90% | 26.41% | Upgrade
|
| Effective Tax Rate | - | 10.44% | 13.62% | 13.52% | 14.44% | 14.34% | Upgrade
|
| Revenue as Reported | 17,049 | 26,070 | 52,918 | 38,264 | 30,652 | 15,190 | Upgrade
|
| Advertising Expenses | - | 395.29 | 475.81 | 395.05 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.